6Saag MS, Graybill RJ, Larsen RA, et al. Practi ce guidelinesfor the management of cryptococcal disease [J]- Clin InfectDis, 2000, 30: 710-718.
7Pfaller MA, Diekema DJ, Gibbs DL, et al. Results fromtheARTEMIS DISK Global Antifungal Surveillance Study?1997 to 2007: 10. 5-year analysis of susceptibilities of noncan-didal yeastspecies to fluconazole and voriconazole determinedby CLSIstandardized disk diffusion testing[J]. J Clin Microbi-ol,2009,47(1): 117-123.
8Sar B,Monchy D,VannM,et al. Increasing in vitro resistanceto fluconazolein Cryptococcus neoform ans Cambodian isolates:April 2000 to March 2002[J], Antimi crob Chemother, 2004,54(2): 563-565.
